CLOVER Trademark

Trademark Overview


On Tuesday, August 31, 2021, a trademark application was filed for CLOVER with the United States Patent and Trademark Office. The USPTO has given the CLOVER trademark a serial number of 79323024. The federal status of this trademark filing is REGISTERED as of Tuesday, January 31, 2023. This trademark is owned by Clover Biopharmaceuticals Ireland Limited. The CLOVER trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of infectious diseases, respiratory diseases, cancer, and autoimmune disorders; antibiotics; vaccines; antibodies, namely, monoclonal and polyclonal antibodies for the diagnosis, treatment, and prevention of infectious diseases, respiratory diseases, cancer, and autoimmune disorders; anti-cancer preparations; antivirals; pharmaceutical preparations for treating respiratory diseases

Pharmaceutical drug development services; pharmaceutical research services; conducting early evaluations in the field of new pharmaceuticals; biological research; providing medical and scientific research information in the field of clinical trials; research and development services in the field of antibiotics; research and development services in the field of vaccines; research and development services in the field of antibodies; research and development services in the field of anti-cancer preparations; research and development services in the field of antivirals; research and development services in the field of respiratory diseases; biotechnology research
clover

General Information


Serial Number79323024
Word MarkCLOVER
Filing DateTuesday, August 31, 2021
Status700 - REGISTERED
Status DateTuesday, January 31, 2023
Registration Number6966071
Registration DateTuesday, January 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of infectious diseases, respiratory diseases, cancer, and autoimmune disorders; antibiotics; vaccines; antibodies, namely, monoclonal and polyclonal antibodies for the diagnosis, treatment, and prevention of infectious diseases, respiratory diseases, cancer, and autoimmune disorders; anti-cancer preparations; antivirals; pharmaceutical preparations for treating respiratory diseases
Goods and ServicesPharmaceutical drug development services; pharmaceutical research services; conducting early evaluations in the field of new pharmaceuticals; biological research; providing medical and scientific research information in the field of clinical trials; research and development services in the field of antibiotics; research and development services in the field of vaccines; research and development services in the field of antibodies; research and development services in the field of anti-cancer preparations; research and development services in the field of antivirals; research and development services in the field of respiratory diseases; biotechnology research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameClover Biopharmaceuticals Ireland Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIE

Party NameClover Biopharmaceuticals Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIE

Party NameClover Biopharmaceuticals Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIE

Trademark Events


Event DateEvent Description
Saturday, November 25, 2023NEW REPRESENTATIVE AT IB RECEIVED
Thursday, November 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 30, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 4, 2023FINAL DISPOSITION PROCESSED
Sunday, April 30, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 5, 2022REFUSAL PROCESSED BY IB
Saturday, June 11, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 10, 2022REFUSAL PROCESSED BY MPU
Wednesday, June 8, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 7, 2022NON-FINAL ACTION WRITTEN
Monday, June 6, 2022ASSIGNED TO EXAMINER
Friday, December 3, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 12, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 19, 2021APPLICATION FILING RECEIPT MAILED
Friday, October 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 14, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB